Analyst Ratings for Larimar Therapeutics (LRMR)
LRMR Rating Summary
LRMR Price Target Summary
- Highest: $26.00 (Guggenheim)
- Lowest: $7.00 (Baird)
- Average: $15.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.00 (+332.3%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$15.00 (+332.3%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/27/2026 | JPMorgan | Tessa Romero | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.45 (3.47) |
0.58% | Details |
| 1/5/2026 | Leerink | Joseph Schwartz | New Coverage | Outperform (N/A) |
12.00 (N/A) |
3.47 (3.47) |
0% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
